In episode 14 of the Ori Spotlight Podcast, Jason C. Foster is joined by John Connolly, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy, who explained why and how the industry needs to increase the accessibility of CGT for patients.
The Parker Institute is a research institute on a mission – to break down infrastructure barriers that have slowed progress in the development of immunotherapies. Their infrastructure builds collaboration between researchers, non-profits and industry organizations to bring treatments to patients faster.
John sat down with Jason to discuss the value of academia and industry collaborations, the importance of flexibility and scalability in CGT manufacturing, and how as an industry we should measure the success of CGT.
Learn more about:
John Connolly
Learn more about Parker Institute for Cancer Immunotherapy
Ori Biotech Ltd 2022 © All rights reserved. Oribiotech is registered in England and Wales. Company registration 09757696.